BLRX Stock Analysis: Buy, Sell, or Hold?
BLRX - BioLineRX Ltd
$3.00
0.19 (6.76%)
▲
5d:
+13.64%
30d:
+6.38%
90d:
-1.96%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 27, 2026
1d
Get Alerted When BLRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BLRX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BLRX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: BLRX is currently trading at $3.00, which is considered extended relative to its 30-day fair value range of $2.71 to $2.88.
Technical Outlook: Technically, BLRX is in a uptrend. Immediate support is located at $2.60, while resistance sits at $3.10. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: BLRX scores 18/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $23.00 (+666.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BLRX is in a uptrend. Immediate support is located at $2.60, while resistance sits at $3.10. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: BLRX scores 18/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $23.00 (+666.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.71 -
$2.88
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
31.6%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (18/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.8%)
- BULLISH: Trading 666.7% below Wall St target ($23.00)
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.71 -
$2.88
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.60
Resistance Level
$3.10
Current Trend
Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
93.46
Wall Street Target
$23.00
(+666.7%)
Revenue Growth (YoY)
87.1%
Share & Embed Analysis
Last updated: August 25, 2026 6:31 AM ET
Data refreshes hourly during market hours. Next update: 7:31 AM
Data refreshes hourly during market hours. Next update: 7:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$370 | 42 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 38 SELL |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 39 SELL |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$560 | 30 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$313 | 50 HOLD |
